You are here

Pluristem

NASA-partnered Pluristem crashes to Earth as it axes leading therapy

Fierce Biotech

Thu, 12/10/20 - 10:48 am

clinical trials

critical limb ischemia

Pluristem’s cell therapies head for orbit with NASA deal

Fierce Biotech

Wed, 02/20/19 - 10:12 am

Pluristem Reports Positive Top-Line PhII Results From Its Placenta Derived Cell Therapy In Peripheral Artery Disease

CP Wire

Tue, 06/12/18 - 11:24 am

intermittent claudication

Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment

Endpoints

Wed, 06/21/17 - 10:57 am

Sarepta Therapeutics

Duchenne Muscular Dystrophy

Pluristem shares jump 5.4% premarket as FDA approves trial of treatment for critical limb ischemia

Marketwatch

Tue, 01/10/17 - 09:18 am

clinical trials

critical limb ischemia

Pluristem reports 1Q loss

Yahoo/AP

Tue, 11/15/16 - 09:21 am

Pluristem Receives U.S. FDA Clearance to Initiate Clinical Trial of PLX-R18 to Treat Insufficient Hematopoietic Recovery Following Bone Marrow Transplant

Yahoo

Tue, 01/12/16 - 08:57 am

clinical trials

bone marrow transplants

Pluristem posts loss of $5.3 million in 4th quarter

Yahoo/AP

Thu, 09/10/15 - 10:07 am

Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials

Yahoo

Thu, 08/13/15 - 08:42 am

Pluristem Issues Letter to Shareholders

Yahoo

Tue, 05/26/15 - 09:35 am

Pluristem Announces Significant New Finding From Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months

Yahoo

Mon, 02/2/15 - 07:48 am

hip arthroplasty

Pluristem posts loss of $5.9 million in first quarter

Yahoo/AP

Fri, 11/21/14 - 08:29 am

Pluristem Gains Most in 17 Months on Stem-Cell Study

Bloomberg

Tue, 01/21/14 - 08:25 am

muscle injuries

Mesoblast Is No Match For Pluristem's IP And Manufacturing

Seeking Alpha

Thu, 01/16/14 - 07:26 am

Pluristem's Promising GvHD Indication Pits It Against Osiris

Seeking Alpha

Tue, 10/8/13 - 08:41 am

graft vs host disease

FDA lifts hold on Pluristem's stem cell trial after tweaking protocol

Fierce Biotech

Mon, 09/16/13 - 11:07 am

intermittent claudication

Celgene's And Osiris' IP Positions Weakened By Pluristem's Pivotal Patent

Seeking Alpha

Thu, 09/12/13 - 10:20 am

placental-based cells

Biotech: A Scattershot Of Stem Cell Plays Following Yesterday's Bloodbath

Seeking Alpha

Wed, 08/28/13 - 09:52 am

BrainStorm Cell Therapeutics

Korean Partner Positions Pluristem To Be Cell Therapy Leader

Seeking Alpha

Tue, 07/2/13 - 01:40 am

Advanced Cell Technology

Cha Bio&Diostech

Pluristem, Cha forge partnership for Korean market

Reuters

Wed, 06/26/13 - 09:32 am

Cha Bio&Diostech

peripheral artery disease

Pages